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Abstract
Hypoxia-inducible factor (HIF)-1alpha is the oxygen-sensitive subunit of HIF-1, a transcriptional master
regulator of oxygen homeostasis. Oxygen-dependent prolyl hydroxylation targets HIF-1alpha for
ubiquitinylation and proteasomal degradation. Unexpectedly, we found that exposing mice to elevated
temperatures resulted in a strong HIF-1alpha induction in kidney, liver, and spleen. To elucidate the
molecular mechanisms responsible for this effect, HepG2 hepatoma cells were exposed to different
temperatures (34-42 degrees C) under normoxic (20% O(2)) or hypoxic (3% O(2)) conditions. Heat was
sufficient to stabilize mainly a phosphatase-resistant, low molecular weight form of HIF-1alpha (termed
HIF-1alpha(a)). Heat-induced HIF-1alpha(a) accumulated in the nucleus but neither bound to DNA nor
trans-activated reporter or target gene expression, demonstrating the need for post-translational
modifications for these functions. The protein banding pattern of heat-induced HIF-1alpha in
immunoblot analyses was clearly distinct from the HIF-1alpha pattern after prolyl hydroxylase
inhibition (by hypoxia or iron chelation/replacement) or following proteasome inhibition, suggesting
that heat stabilizes HIF-1alpha by a novel mechanism. Inhibition of the ATP-dependent chaperone
activity of HSP90 by novobiocin or geldanamycin prevented heat-induced as well as hypoxia-induced
HIF-1alpha accumulation, indicating a common role of the HSP90 chaperone activity in HIF-1alpha
stabilization by these two environmental parameters.
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SUMMARY 
 Hypoxia-inducible factor (HIF)-1α is the oxygen-sensitive subunit of HIF-1, a 
transcriptional master regulator of oxygen homeostasis. Oxygen-dependent prolyl 
hydroxylation targets HIF-1α for ubiquitinylation and proteasomal degradation. Unexpectedly, 
we found that exposing mice to elevated temperatures resulted in a strong HIF-1α induction in 
kidney, liver and spleen. To elucidate the molecular mechanisms responsible for this effect, 
HepG2 hepatoma cells were exposed to different temperatures (34°C-42°C) under normoxic 
(20% O2) or hypoxic (3% O2) conditions. Heat was sufficient to stabilize mainly a 
phosphatase-resistant, low molecular weight form of HIF-1α (termed HIF-1αa). Heat-induced 
HIF-1αa accumulated in the nucleus but neither bound to DNA nor trans-activated reporter or 
target gene expression, demonstrating the need of post-translational modifications for these 
functions. The protein banding pattern of heat-induced HIF-1α in immunoblot analyses was 
clearly distinct from the HIF-1α pattern after prolyl hydroxylase inhibition (by hypoxia or iron 
chelation/replacement) or following proteasome inhibition, suggesting that heat stabilizes HIF-
1α by a novel mechanism. Inhibition of the ATP-dependent chaperone activity of HSP90 by 
novobiocin or geldanamycin prevented heat-induced as well as hypoxia-induced HIF-1α 
accumulation, indicating a common role of the HSP90 chaperone activity in HIF-1α 
stabilization by these two environmental parameters. 
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INTRODUCTION 
 The hypoxia-inducible factor-1 (HIF-1)1 is a heterodimeric transcription factor 
composed of the two subunits HIF-1α and HIF-1β, both belonging to the basic-helix-loop-
helix (bHLH)-Per/Arylhydrocarbon receptor (AhR) nuclear translocator (ARNT)/Sim (PAS) 
protein superfamily (1). HIF-1β is identical to the previously described ARNT protein. HIF-1 
is a critical regulator of the physiological adaptive response to hypoxia since it activates genes 
regulating among others angiogenesis, erythropoiesis and glucose metabolism. HIF-1 has also 
been described to be involved in tumor-angiogenesis and ischemic diseases such as myocardial 
ischemia or stroke (reviewed in refs. 2,3). Whereas ARNT is constitutively expressed, HIF-1α 
expression is induced in hypoxic cells with an exponential increase in expression as cells are 
exposed to decreased oxygen partial pressures. As determined in HeLa cells, highest HIF-1α 
protein levels are reached at 0.5% oxygen (4,5). Recent studies have shown that HIF-1α is 
modified by oxygen-dependent prolyl hydroxylation (6-9), allowing the binding of the von 
Hippel-Lindau protein (pVHL) which targets HIF-1α for ubiquitinylation and proteasomal 
degradation (10-17). Further activation of HIF-1 involves nuclear translocation, dimerization 
with ARNT, DNA-binding and recruitment of transcriptional co-activators. These processes 
are regulated at least in part by posttranslational modifications. It has been demonstrated that 
phosphorylation of HIF-1α via the Ras/Raf-MEK-p42/44 and the PI3K-PTEN-Akt-GSK3 
kinase pathways eventually results in elevated expression and/or transcriptional activity of 
HIF-1 (18-21). 
 The protein chaperone complex heat shock protein (HSP)90-p23 (reviewed in refs. 
22,23) is involved in the regulation of a variety of bHLH transcription factors including MyoD 
and the bHLH-PAS proteins Sim and AhR (24-26). HSP90 interacts with two different sites of 
AhR, one in the bHLH domain and the other in the PAS B domain (26,27). The interaction of 
HSP90 with the ligand binding domain of AhR is important for maintaining the receptor in a 
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high-affinity ligand binding and repressed conformation (28-30). Furthermore, the HSP90 
chaperone complex seems to regulate the intracellular localization of the AhR (31). As shown 
by in vitro pull-down assays, HSP90 can also bind HIF-1α (32). This observation has been 
confirmed by co-immunoprecipitation studies using an artificial EGFP-HIF-1α fusion protein 
ectopically over-expressed in heterologous COS-7 cells (33). However, because HSP90 is 
capable of binding many proteins, the functional significance of these observations remained 
unknown. In particular, the effect of physiological activation of HSPs by heat on HIF-1 activity 
has not been reported so far.  
 We therefore investigated the impact of heat shock (as evidenced by HSP90 induction 
and activation) in vivo and in vitro on the regulation of cellular HIF-1α expression, protein 
modifications, subcellular localization as well as HIF-1 DNA-binding and trans-activation 
activity. Our data indicate a novel role of HSP90 in the stabilization of HIF-1α, which is not 
related to proteasome function or posttranslational modification of HIF-1α by phosphorylation.  
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EXPERIMENTAL PROCEDURES 
Antibodies and Chemicals 
 Antibodies were purchased from the suppliers indicated in parentheses: mouse 
monoclonal anti-HSP90 (StressGen), mouse anti-HIF-1α (Novus), mouse anti-pVHL 
(Pharmingen), mouse anti-HIF-1α (Transduction Laboratories), mouse anti-β actin (Sigma). 
Appropriate horseradish peroxidase-labeled secondary antibodies were purchased from 
SantaCruz and Promega. PD98059 and λ protein phosphatase were supplied by Calbiochem 
and New England Biolabs, respectively. All other chemicals were obtained from Sigma. 
Petriperm dishes were purchased from Satorius.  
 
Cell culture and reporter gene assays 
 The human hepatoma cell lines HepG2 and Hep3B were obtained from American Type 
Culture Collection. Cells were grown in high-glucose DMEM containig 10% FCS 
(LifeTechnologies) in a humidified 5% CO2/95% air atmosphere at 37°C. For hypoxic 
exposure, the O2 concentration in the cell culture incubator (Heraeus) was lowered to 3%. The 
B1 cell line (kind gift of J. Caro, Philadelphia, PA) is derived from Hep3B cells stably 
transfected with a reporter gene construct containing the 5' and 3' flanking regions of the 
erythropoietin gene linked to the luciferase reporter gene (10).  
 
Animal experiments 
 The investigations were performed in strict accordance with the Guide for the Care and 
Use of Laboratory Animals (National Institutes of Health publication no. 85-23, revised 1996) 
and approved by the local Governmental Commissions for the Care of Animals. For heat 
treatment, B6C3F1 mice were placed into an 37°C incubator for different time periods. The 
rectal temperature was continuously recorded with a thermocouple. Re-cooling of the animals 
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was accomplished by exposing the animals after heat treatment to 20°C ambient temperature. 
Typically, rectal temperature increased up to 41°C during heat treatment reaching the 
maximum temperature approximately 2 hours after exposing the mice to 37°C. Re-cooling 
resulted in a drop of rectal temperature back to 37°C within 20 min. 
 
Immunoblot analyses 
 Following stimulation, cells were collected, washed with ice-cold PBS and extracted 
with 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 400 mM NaCl, 0.1% NP-40, 1 mM DTT, 1 
μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin, 1 mM PMSF. Protein concentrations 
were determined using the Bradford method (Sigma). Proteins were separated by SDS-PAGE 
and transferred onto nitrocellulose membranes by semi-dry electroblotting (Bio-Rad). 
Membranes were stained with Ponceau S to verify equal protein loading per lane. After 
overnight blocking (5% non-fat milk powder in PBS), the blots were incubated for 1-2 hours 
with primary antibodies against HIF-1α, pVHL, HSP90, or β-actin, and detected with 
secondary horseradish peroxidase-conjugated antibodies. Chemiluminescence detection was 
performed by incubating the membranes with 100 mM Tris-HCl (pH 8.5), 2.65 mM H2O2, 0.45 
mM luminol, and 0.625 mM coumaric acid for 1 min followed by exposure to X-ray films. 
 
Immunofluorescence analyses 
 For immunofluorescence analyses, cells were fixed with freshly prepared 3.7% 
formaldehyde in PBS (pH 7.4) for 10 min, washed with PBS, permeabilized with 0.5% Triton 
X-100 for 5 min, and rinsed again with PBS. After blocking nonspecific binding sites with 3% 
BSA in PBS for 30 min, the cells were incubated for 1 hour with the anti-HIF-1α 
(Transduction Laboratories) or the anti-HSP90 antibody diluted 1:100 in 3% BSA in PBS, 
followed by a FITC-coupled secondary anti-mouse (Dako) antibody diluted 1:100 with 3% 
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BSA in PBS. After extensive washings with PBS, the slides were mounted and analyzed by 
fluorescence microscopy (Axioplan 2000, Zeiss). 
 
Immunoprecipitation analyses 
 Following stimulation, cells were collected, washed with ice-cold PBS and extracted 
with 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 400 mM NaCl, 0.1% NP-40, 1 mM DTT, 1 
μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin, 1 mM PMSF. 1 mg of each protein 
sample was incubated with 26 μg anti HIF-1α (Novus) antibodies and 100 μl protein G/A 
agarose (Oncogene) overnight. Agarose beads were washed three times with lysis buffer 
containing 2 mM sodium molybdate. Immunoprecipitated proteins were recovered by adding 
0.5 M Tris-HCl (pH 6.8), 0.5% SDS, 0.5% bromophenol blue, 20% glycerol. Subsequently, 
samples were freed of agarose beads by filtration through micropure 0.22 separators (Amicon), 
boiled and separated by SDS-PAGE. HIF-1α and HSP90 were detected by immunoblot 
analysis as described above.  
 
RNA extraction and RNA blot analysis 
 Total cellular RNA preparation and RNA blot analysis was carried out as described 
previously (34). Hybridization probes for Glut-1, aldolase and β-actin were obtained by gel-
purification of the inserts and random-primed labelling as described previously (34). 
Radioactive signals were recorded by exposure to phosphoimaging screens (Fuji). 
 
Electrophoretic mobility shift assay (EMSA) 
 EMSA was performed as described before (35). Oligonucleotides containing a HIF-1 
DNA-binding site derived from the erythropoietin gene were gel-purified on 10% 
polyacrylamide gels prior to 5' end-labeling of the sense strand with γ32P-ATP (Amersham). 
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Unincorporated nucleotides were removed by gel filtration over Bio-Gel P60 columns (Bio-
Rad). Labelled sense strands were annealed to a twofold molar excess of unlabelled antisense 
strands. DNA-protein binding reactions were carried out for 4 hours at 4°C in a total volume of 
20 μl 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 50 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 5 
mM DTT, 5% glycerol, containing 5 μg nuclear extract, 0.1 μg sonicated calf thymus DNA 
(Sigma), and 2 x 104 cpm of oligonucleotide probe. Samples were run on 4% nondenaturing 
polyacrylamide gels at 200 V in TBE buffer (89 mM Tris, 89 mM boric acid, 5 mM EDTA) at 
4°C. The gels were dried and radioactive signals were recorded as described above.  
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RESULTS 
 Heat induces HIF-1α expression in vivo―Similar to other bHLH transcription factors, 
HIF-1α can form a stable association with HSP90 in vitro (33,36). To obtain evidence as to 
whether HIF-1α stabilization is functionally linked to activation of the heat shock response in 
vivo, we exposed mice to an ambient temperature of 37°C for up to 4 hours. During this 
treatment the rectal temperature increased up to 41°C as soon as 2 hours of exposure. Three 
animals were re-cooled following 3 hours of 37°C by exposing them back to room temperature. 
Subsequently, animals were sacrificed and HSP90 as well as HIF-1α protein expression was 
determined in kidney, liver, spleen, lung and testis (Fig. 1). In kidney and liver, a strong 
induction of HIF-1α expression was observed as soon as 1 hour after exposure of the mice to 
an ambient temperature of 37°C. This induction was detectable up to 3 hours after re-cooling 
of the animals, although the rectal temperature had decreased back to normal values. In spleen, 
only a slight induction of HIF-1α protein expression with elevated core body temperature was 
observed, whereas in the lung no signal could be detected. In testis, a strong constitutive HIF-
1α protein expression was observed, which remained unaffected by elevated core body 
temperature. Interestingly, heat-induced as well as constitutive expression of HIF-1α protein 
correlated with the expression of HSP90 in the different organs (Fig. 1), suggesting that HSP90 
induction might be functionally linked to HIF-1α stabilization. 
 
 Temperature-dependent HIF-1α protein accumulation―To gain insight into the 
molecular basis of the heat-induced HIF-1α expression, human hepatoma HepG2 cells were 
exposed for 4 hours to temperatures ranging from 34°C to 42°C under normoxic (20% O2) or 
hypoxic (3% O2) conditions. HIF-1α but not pVHL or β-actin protein levels were induced by 
elevated incubation temperatures under both normoxic and hypoxic conditions (Fig. 2A). A 
similar effect was found when desferrioxamine or cobalt chloride were combined with heat 
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(Fig. 2B). Heat-induced expression of HIF-1α started following exposure for 2 hours (data not 
shown). Heat-induced increase in HIF-1α expression was also detectable in petriperm cell 
culture dishes, in which the cells were grown attached to an oxygen-permeable silicone 
membrane. This prevents hypoxic effects that potentially might occur due to increased oxygen 
consumption following heat exposure (data not shown).  
 Three major HIF-1α bands could be resolved by Western blot analysis (termed HIF-
1αa, HIF-1αb, and HIF-1αc) (Fig. 2 and 3). Interestingly, heat induced primarily the low 
molecular weight form HIF-1αa in vitro and to some extent HIF-1αb, whereas hypoxia or the 
hypoxia-mimicking agents cobalt chloride and desferrioxamine induced primarily the higher 
molecular weight species HIF-1αb, HIF-1αc as well as intervening forms (Fig. 2 A and B). To 
determine the biochemical basis of the three HIF-1α forms, protein extracts of HepG2 cells 
exposed to 37°C under hypoxic conditions or exposed to 42°C under normoxic conditions were 
treated with λ phosphatase. The HIF-1αc band disappeared after λ phosphatase (400 U) 
treatment, whereas the HIF-1αa and HIF-1αb bands were not affected (Fig. 3A), even after 
increasing the amount of λ phosphatase up to 2000 U (data not shown). These results suggest 
that HIF-1αc represents a phosphorylated form of HIF-1α. A high-resolution immunoblot with 
the organ protein extracts, derived from mice exposed for 4 hours to elevated temperatures, 
together with a protein extract of hypoxic HepG2 cells, clearly indicated that the HIF-1αa form 
is also induced by heat in vivo (Fig. 3B).  
 
 Heat-induced HIF-1αa translocates into the nucleus under normoxic 
conditions―Immunofluorescence studies were performed to analyze the subcellular 
localization of heat-induced HIF-1αa. As shown in Fig. 4, nuclear accumulation of HIF-1αa 
was detected following exposure of HepG2 cells to hypoxic conditions at 37°C as well as at 
42°C. A similar effect could be observed following exposure of the cells to 42°C at normoxic 
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conditions but not to 37°C. In the same cell line, a strong induction of HSP90 was observed at 
42°C in the cytoplasm as well as in the nucleus. Because the same antibody was used for  the 
immunoblot and immunofluorescence studies, it has to be assumed (though this can not 
formally proven) that all three forms of HIF-1α, i.e. HIF-1αa-c, are recognized in the 
immunofluorescence experiments as well. Strikingly, nuclear HSP90 was detected under 
hypoxic conditions at 37°C. Neither these immunofluorescence nor Western blot analyses (data 
not shown) provided evidence for an increase of total HSP90 cellular protein under hypoxic 
conditions, indicating that hypoxia induces nuclear translocation of HSP90.  
 
 Heat induces HIF-1αa but not HIF-1 trans-activation activity―Next, we analyzed the 
functional activities of heat-induced compared with hypoxia-induced HIF-1α. Therefore, 
DNA-binding and reporter gene studies were performed. Despite the increase in protein 
concentration, exposing cells to 42°C did not result in increased DNA-binding activity (Fig. 
5A). Consequently, the transcriptional activity of heat-induced HIF-1 remained unchanged in 
B1 cells exposed to 42°C (Fig. 5B). Since the luciferase protein was found to be thermoinstable 
(data not shown and ref. (37), reporter gene expression was determined at the mRNA level. In 
contrast to heat, exposing B1 cells to hypoxia resulted in a strong induction of luciferase 
mRNA expression, which was not further increased by heat.  
Finally, HIF-1 target gene expression was evaluated following exposure to heat and/or 
hypoxia. In agreement with the lack of DNA-binding and heat-induced reporter gene activity, 
hypoxia but not heat induced the HIF-1 target genes glucose transporter-1 (Glut-1) and 
aldolase  in HepG2 cells (Fig. 5C). In the same samples, no change in HIF-1α mRNA 
expression was detectable, demonstrating that neither hypoxia nor heat-induced HIF-1α protein 
expression is caused by increased mRNA expression. 
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 Heat-induction of HIF-1αa, b is not caused by inhibition of prolyl hydroxylation or 
proteasomal activity― There are several possible regulatory steps during which heat might 
block the HIF-1α degradation process, including prolyl hydroxylation, ubiquitinylation and 
proteasomal degradation. By high-resolution Western blotting, HIF-1α was detected as 
multiple bands, designated HIF-1αa (likely to represent the native HIF-1α protein), HIF-1αb 
(representing a phosphatase-resistant form) and HIF-1αc (representing the phosphorylated 
form). Interestingly, the protein banding pattern of HIF-1α induced by heat corresponded to the 
pattern obtained with recombinant HIF-1α in vitro transcribed and translated (IVTT) in rabbit 
reticulocyte lysates (Fig. 6). Because the HIF-1αa and HIF-1αb bands were still present in 
IVTTs performed in the presence of the iron chelator DFX (Fig. 6), an inhibitor of HIF-1α 
prolyl hydroxylation (6,7), it is unlikely that HIF-1αb is the hydroxylated form of HIF-1α. 
These results were confirmed by IVTTs performed under hypoxic conditions (data not shown).  
Compared with heat and IVTT, hypoxia resulted in a distinct HIF-1α banding pattern. 
Hypoxia induced the phosphatase treatment-resistant HIF-1αb and the phosphorylated HIF-1αc 
species the latter of which is not found following heat or IVTT. This observation suggests that 
heat induced HIF-1α at least partially by a pathway distinct from hypoxia. We further excluded 
heat-mediated proteasome inhibition as a potential mechanism of HIF-1α stabilization, as 
evidenced by the distinct pattern of HIF-1α following treatment of the cells with the 
proteasome inhibitor lactacystin (Fig. 6). Unlike heat, lactacystin induced a series of additional 
(most probably poly-ubiquitinylated) HIF-1 bands with lower electrophoretic mobilities than 
HIF-1α a, b and c (Fig. 6).  
 HSP90 activity is required for HIF-1α induction by heat as well as by hypoxia―The 
HSP90-inhibiting drugs novobiocin and geldanamycin were used to gain insight into a possible 
contribution of HSP90 activity to the heat-induced expression of HIF-1α. Therefore, HepG2 
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cells were subjected to 42°C with or without the addition of increasing concentrations of 
novobiocin or geldanamycin (Fig. 7A). It is important to note that the doses of geldanamycin 
and novobiocin employed were not cytotoxic as determined by MTT survival assay (data not 
shown). At lower doses, both HSP90 inhibitors diminished the prominent heat-induced HIF-
1αa form, but led to an increase of the HIF-1αb form. Higher doses of both HSP90 inhibitors 
even led to the disappearance of heat-induced HIF-1αa and HIF-1αb. The addition of the MEK1 
inhibitor PD98059 did not affect heat induction of HIF-1αa and HIF-1αb, confirming that the 
MEK-ERK kinase pathway is not involved in heat regulation of HIF-1α (Fig. 7A). 
 The direct interaction of HIF-1α and HSP90 was determined by co-
immunoprecipitation assays in protein extracts of HepG2 cells exposed to 37°C compared to 
42°C. In good agreement with the hypothesis that HSP90 is mediating heat-induced 
stabilization of HIF-1α, more HSP90 was found to be complexed with HIF-1α after exposure 
to 42°C compared to 37°C (Fig. 7B).  
 Of note, the HSP90 inhibitor geldanamycin was able to diminish also the hypoxia-
induced expression of HIF-1α (Fig. 7C). At lower doses the native HIF-1αa form was more 
susceptible to inhibition of HSP90 activity than the phosphorylated HIF-1αc form. These data 
indicate that protein stabilization of HIF-1α by heat as well as by hypoxia involves ATP-
dependent HSP90 activity.  
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DISCUSSION 
 Early work on hypoxia-inducible gene expression suspected mechanisms comparable to 
those elicited by the general stress response, most prominently represented by the heat-shock 
response. However, with the discovery of HIF-1 it became evident that the specific hypoxic 
response is distinct from the heat-shock response (38). Thus, we were surprised to find heat-
induction of HIF-1α in mice exposed to elevated temperatures. It seems unlikely that heat-
induced HIF-1α expression is simply mediated by hypoxia due to an increased oxygen 
consumption since the temperature effects were similar in standard polystyrol cell culture 
dishes and in petriperm dishes, in which the cells grow attached to oxygen-permeable silicone 
membranes. As previously shown in our laboratory, this prevents hypoxic effects caused by 
high cell densities or increased metabolic rates (39). More important, the protein pattern of 
HIF-1α induced by heat was clearly distinct from the pattern induced by hypoxia: while heat 
induced mainly the native form of HIF-1α (HIF-1αa), hypoxia induced a series of additional 
bands with lower electrophoretic mobilities (HIF-1αb and c), which were prone (HIF-1αc) or 
resistant (HIF-1αb) to phosphatase treatment. Although we can not fully exclude that secondary 
hypoxia plays an additional role for heat-induced HIF-1α induction in vivo, our data indicate 
that the mechanism of heat-induced HIF-1α expression in vivo appear to be similar to the 
mechanism found in vitro since also the HIF-1αa form is induced by heat in vivo. Thus, heat-
induced protein expression is mainly due to protein stabilization and to a lesser extent 
dependent on protein modifications. In line with this notion, Jewell et al. reported that 
immediately after the onset of hypoxia, the high-mobility (native) form of HIF-1α became first 
detectable on Western blots, whereas following prolonged exposure additional (modified) 
forms with lower electrophoretic mobility became apparant (5).  
 The treatment with the HSP90 inhibitors novobiocin or geldanamycin prevented heat-
induced as well as hypoxia-induced HIF-1α expression. Geldanamycin and novobiocin 
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specifically bind to ATP-binding pockets of HSP90, blocking the ATP-dependent maturation 
process of HSP90-dependent complexes in an intermediate state by interfering with the 
association of HSP90 with Hsc70, and finally the recruitment of the co-chaperone p23, that has 
been reported to stabilize the interaction between HSP90 and HSP90-regulated proteins 
(40,41). Occupancy of the ATP binding pocket by ansamycin drugs prevents refolding of 
mature proteins and causes the degradation of HSP90-regulated proteins (42,43). Thus, the 
chaperone activity of HSP90 is involved in HIF-1α stabilization and an increase in HSP90 
protein by heat might stabilize HIF-1α even under normoxic conditions. 
 HSP90 is a highly conserved and abundant protein in the cytosol of both eukaryotic and 
prokaryotic cells (22,23). It represents the most abundant heat shock protein under normal 
conditions and is upregulated by various stress conditions including heat. HSP90 functions as a 
general molecular chaperone in vitro and in vivo, acts in concert with many other heat shock 
and non-heat shock proteins and shows a broad substrate specificity. The chaperone complex 
HSP90-p23 has impact on the regulation of a variety of bHLH transcription factors including 
AhR and Sim as well as various protein kinases such as pp60v-src, steroid hormone receptors 
and the tumor suppressor p53 (24-26,44). Many of these proteins are activated by binding of 
ligands. HSP90 is thought to stabilize these proteins and maintain them in an activatable form. 
Especially for bHLH transcription factors like AhR and Sim, the release of HSP90 appears to 
be required for activation, since only the repressed, non-DNA-binding forms of the receptors 
show interaction with HSP90. Although a protein interaction of HSP90 with HIF-1α has been 
described previously (33,36), the functional meaning of this interaction was not clear so far. 
We show for the first time that the heat-induced stabilization of HIF-1α is linked to the 
function of HSP90. The correlation of HSP90 and heat-induced as well as constitutive HIF-1α 
expression in the animal experiments suggest a general role of HSP90-mediated stabilization of 
HIF-1α also in vivo. In accordance with the depressing function of HSP90 for other bHLH 
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transcription factors, the heat-induced HIF-1α was functionally inactive as demonstrated by 
DNA-binding and reporter gene assays as well as by the lack of target gene expression. This 
suggests that additional posttranslational modifications of HIF-1α are required to activate these 
functions.  
 Heat induction of HIF-1α was sufficient to induce nuclear translocation of the HIF-1αa 
form. Concomitantly, a tremendous induction and nuclear accumulation of HSP90 was 
observed. Thus, it is tempting to speculate that HSP90 itself inhibited the DNA-binding 
activity of the native HIF-1α-ARNT complex. Following hypoxic induction, however, HIF-1α 
becomes activated by phosphorylation (and/or other modifications) which might prevent the 
interaction with HSP90. Accordingly, heat did not inhibit DNA-binding or reporter gene 
activation under hypoxic conditions. Similar data have been reported for the function of HSP90 
in glucocorticoid receptor regulation. Applying heat stress to both cell cultures or whole 
organisms led to considerable loss of cytosolic glucocorticoid binding capacity that coincided 
with a decreased amount of the glucocorticoid receptor protein present in the cytosolic fraction 
and its increase in the nuclei (45-47). Since we were able to demonstrate a slight nuclear 
accumulation of HSP90 after hypoxic versus normoxic exposure at normothermic temperature, 
one could postulate a physiologic role of the HSP90-HIF-1α interaction for the hypoxic 
activation of HIF-1. In analogy to AhR and Sim, HSP90 could support the conformational 
maturation of HIF-1α and protect it from proteasomal degradation. This hypothesis is further 
substantiated by the study of Minet et al., who demonstrated that inhibition of the function of 
HSP90 with geldanamycin impaired CoCl2-induced HIF-1α activation as determined by 
reporter gene assays in transiently transfected cells (33). In agreement with this model we 
found that the HSP90 inhibitor geldanamycin was able to inhibit hypoxic stabilization of HIF-
1α. 
Heat-induced HIF-1α protein stabilization 17
 In summary, our studies imply that HSP90 plays a functional role in HIF-1 regulation 
by physiologic variations of both environmental parameters oxygen partial pressure and 
temperature. 
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FIGURE LEGENDS 
 
 FIG. 1. Heat induces HIF-1α expression in vivo. Mice were exposed to an ambient 
temperature of 37°C for different time intervals and were then either sacrificed directly after 
the heat treatment or re-cooled by re-exposure to 20°C. Subsequently, HIF-1α, HSP90 and β-
actin protein expression was determined in organ protein extracts. A representative 
immunoblot analysis of cellular protein probed with anti-HIF-1α, anti-HSP90 or anti-β-actin 
antibodies is shown.  
 
 FIG. 2. Heat induces HIF-1α expression in vitro. (A) Induction of HIF-1α protein 
after exposure of HepG2 cells to 34 - 42°C under normoxic (20% O2) or hypoxic (3% O2) 
conditions for 4 hours. A representative immunoblot analysis of cellular protein probed with 
anti-HIF-1α, anti-pVHL and anti-β-actin antibodies is shown. (B) Induction of HIF-1α protein 
after exposure of HepG2 cells to 125 μM desferrioxamine (DFX) or 50 μM CoCl2 at 37°C or 
42°C for 4 hours. Representative immunoblot analysis probed with anti-HIF-1α 
 
FIG. 3 Heat induces non-phosphorylated HIF-1α. (A) HepG2 cells were exposed to 
37°C under hypoxic conditions or 42°C under normoxic conditions. Cell lysates were then 
treated with or without 400 U λ phosphatase. Representative immunoblot  analysis probed with 
anti-HIF-1α. (B) Organ protein extracts of mice exposed for 4 hours to an ambient temperature 
of 37°C were analyzed together with a protein extract of HepG2 cells exposed for 4 hours to 
3% O2 by high-resolution HIF-1α immunoblotting.  
 
 FIG. 4. Subcellular localization of HIF-1α. HepG2 cells were exposed to 37°C or 
42°C under normoxic (20% O2) or hypoxic (3% O2) conditions for 4 hours. The cells were 
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prepared for immunofluorescence analysis and incubated with anti-HIF-1α or anti-HSP90 
antibodies followed by FITC-conjugated secondary antibodies as described in Experimental 
Procedures.  
 
 FIG. 5. Heat-induction of HIF-1α is not sufficient for induction of HIF-1 trans-
activation activity. (A) Lack of heat-induced HIF-1 DNA-binding. HepG2 cells were 
incubated at 37°C and 42°C under normoxic (20% O2) or hypoxic (3% O2) conditions for 4 
hours. Nuclear protein was extracted and incubated with 32P-labelled oligonucleotides 
containing the wild type or a mutant HIF-1 binding site derived from the erythropoietin 3' 
hypoxia response element. Antibodies were added to the samples where indicated to confirm 
the specificity of the supershifted (ss) protein-DNA complexes. (B) Luciferase mRNA 
Northern blotting of B1 cells (Hep3B cells stably transfected with the regulatory elements of 
the erythropoietin gene linked to the luciferase reporter gene ) exposed to 37°C and 42°C under 
normoxic (20% O2) or hypoxic (3% O2) conditions for 4 hours. Shown are mean values ± 
standard deviation of three independent experiments. (C) Northern blotting of HepG2 cells 
exposed to 37°C and 42°C under normoxic (20% O2) or hypoxic (3% O2) conditions for 4 
hours using radioactively labeled cDNA probes for glucose transporter-1 (Glut-1), aldolase, 
HIF-1α and β-actin mRNA. 
 
 FIG. 6. Distinct banding patterns of HIF-1α are induced by heat, hypoxia and 
proteasomal inhibition. HepG2 cells were exposed to the indicated temperatures or oxygen 
concentrations with or without the addition of lactacystin for 4 hours. Representative 
immunoblot analysis of cellular protein or recombinant HIF-1α, in vitro transcribed/translated 
(IVTT) with or without the presence of 125 µM DFX, probed with anti-HIF-1α antibodies.  
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 FIG. 7. HSP90 activity is required for both heat and hypoxic induction of HIF-1α. 
(A) HepG2 cells were incubated at 37°C or 42°C under normoxic (20% O2) or hypoxic (3% 
O2) conditions for 4 hours with or without the addition of the HSP90 inhibitor novobiocin and 
geldanamycin (GM) or the MEK1 inhibitor PD98059. (B) HepG2 cells were incubated at 37°C 
or 42°C for 4 hours under normoxic conditions. Subsequently protein extracts were prepared 
and the HIF-1α/HSP90 interaction detected by co-immunoprecipitation assays using anti-HIF-
1α antibodies. (C) HepG2 cells were incubated at 37°C under hypoxic (3% O2) conditions for 
4 hours with or without the addition of geldanamycin (GM). Representative immunoblot 
analyis of cellular protein probed with anti-HIF-1α and anti-β-actin antibodies. 
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